|
|
| | ANTI-CPLA2 Basic information |
| Product Name: | ANTI-CPLA2 | | Synonyms: | ANTI-CPLA2;Anti-Phospholipase a2, group ivc (cytosolic, calcium-independent);Anti-PLA2G4C antibody produced in rabbit;Anti-CPLA2-alpha;Anti-cytosolic phospholipase A2;Anti-Group IVA;Anti-Phospholipase A2 (CPLA2) antibody produced in rabbit;Anti-PLA2G4A PLA2G4 | | CAS: | | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![ANTI-CPLA2 Structure]() |
| | ANTI-CPLA2 Chemical Properties |
| storage temp. | -20°C | | form | buffered aqueous solution |
| Hazard Codes | Xn | | Risk Statements | 22 |
| | ANTI-CPLA2 Usage And Synthesis |
| Uses | Anti-Phospholipase A2 (cPLA2) (N-terminal) antibody produced in rabbit may be used in immunoblotting and immunoprecipitation. | | General Description | CPLA2/PLA2G4A (phospholipase A2, group IVA(cytosolic, calcium-dependent)) is located on human chromosome 1q31.1. cPLA2α is an 85?kDa protein made of 749 amino acids. It is a member of the the α-β hydrolase family. CPLA2 has an N-terminal C2 domain (Ca2+ - dependent, phospholipid binding) and two catalytic domains (α/β hydrolase). This protein is located in the cytoplasm. | | Biochem/physiol Actions | CPLA2/PLA2G4A (phospholipase A2, group IVA(cytosolic, calcium-dependent)) helps to hydrolyze phospholipids at the sn-2-acyl ester bond to generate free fatty acid and lysophospholipid second messengers. It is associated with several diseases like cardiovascular disease, diabetes, asthma and arthritis. |
| | ANTI-CPLA2 Preparation Products And Raw materials |
|